PSMD13
26S proteasome non-ATPase regulatory subunit 13
Also known as: p40.5, PSD13_HUMAN, Rpn9
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UNM6
- Gene
- PSMD13
- Ensembl
- ENSG00000185627
- Chromosome
- 11
- Canonical length
- 376 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nuclear speckles,Cytosol
OverviewNCBI Gene
The 26S proteasome is a multicatalytic proteinase complex with a highly ordered structure composed of 2 complexes, a 20S core and a 19S regulator. The 20S core is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. The 19S regulator is composed of a base, which contains 6 ATPase subunits and 2 non-ATPase subunits, and a lid, which contains up to 10 non-ATPase subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a non-ATPase subunit of the 19S regulator. Two transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
376 residues, UniProt reviewed canonical sequence.
>Q9UNM6|PSMD13
1 MKDVPGFLQQ SQNSGPGQPA VWHRLEELYT KKLWHQLTLQ VLDFVQDPCF AQGDGLIKLY
61 ENFISEFEHR VNPLSLVEII LHVVRQMTDP NVALTFLEKT REKVKSSDEA VILCKTAIGA
121 LKLNIGDLQV TKETIEDVEE MLNNLPGVTS VHSRFYDLSS KYYQTIGNHA SYYKDALRFL
181 GCVDIKDLPV SEQQERAFTL GLAGLLGEGV FNFGELLMHP VLESLRNTDR QWLIDTLYAF
241 NSGNVERFQT LKTAWGQQPD LAANEAQLLR KIQLLCLMEM TFTRPANHRQ LTFEEIAKSA
301 KITVNEVELL VMKALSVGLV KGSIDEVDKR VHMTWVQPRV LDLQQIKGMK DRLEFWCTDV
361 KSMEMLVEHQ AHDILTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PSMD13 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 163 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 163 nTPM
- tongue: 116 nTPM
- thymus: 85 nTPM
- tonsil: 81 nTPM
- heart muscle: 77 nTPM
- spleen: 75 nTPM
Single-cell type
- syncytiotrophoblasts: 250 nCPM
- cytotrophoblasts: 193 nCPM
- extravillous trophoblasts: 168 nCPM
- migrating cytotrophoblasts: 163 nCPM
- megakaryocytes: 161 nCPM
- esophageal apical cells: 132 nCPM
Immune cell
- total PBMC: 286 nTPM
- basophil: 199 nTPM
- non-classical monocyte: 196 nTPM
- myeloid DC: 176 nTPM
- intermediate monocyte: 173 nTPM
- classical monocyte: 172 nTPM
Brain region
- pons: 36 nTPM
- hypothalamus: 32 nTPM
- white matter: 32 nTPM
- spinal cord: 29 nTPM
- medulla oblongata: 27 nTPM
- midbrain: 27 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.19
- gnomAD pLI
- 1
- gnomAD missense Z
- 0.63
- DepMap mean gene effect
- -1.01
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- meiosis I
- proteasome-mediated ubiquitin-dependent protein catabolic process
- ubiquitin-dependent protein catabolic process
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Proteasome component (PCI) domain
- Winged helix DNA-binding domain superfamily
- PCI domain
- 26S Proteasome non-ATPase regulatory subunit 13
- PSD13, N-terminal
- PSD13 N-terminal repeats
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PSMD13 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PSMD13 as an antibody target. Whether an autoantibody or antibody against PSMD13 could matter depends on whether native PSMD13 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PSMD13 is annotated as secreted, so native PSMD13 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label PSMD13 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...